TurningPointTherapeutics (NASDAQ:TPTX) Downgradedby JMPSecurities to MarketPerform

TurningPointTherapeutics} stock has undergone multiple analysts rating changes in the recent past.  TurningPointTherapeutics Downgradedby JMPSecurities on 10/11/2021. In a note to investors, the firm issued a new rating of MarketPerform. The analysts previously had rating of Outperform.

View More TurningPointTherapeutics (NASDAQ:TPTX) Downgradedby JMPSecurities to MarketPerform